CMPI

Checkmate Pharmaceuticals, Inc. Common Stock

Delisted

CMPI was delisted on the 27th of May, 2022.

31 hedge funds and large institutions have $64.5M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.

Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.54%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
3
Increased
5
Reduced
8
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$6K +$6K +1,426 New
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$1K -$26.9K -4,972 -96%
UBS Group
28
UBS Group
Switzerland
$1K -$17K -3,113 -94%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$1K -$13.2K -2,219 -93%
JMF
30
Johnson Midwest Financial
Iowa
$1K
Deutsche Bank
31
Deutsche Bank
Germany
-$803K -134,760 Closed
Millennium Management
32
Millennium Management
New York
-$241K -40,422 Closed
AIMCA
33
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$149K -25,000 Closed
ASN
34
Advisory Services Network
Georgia
-$46K -7,800 Closed